MYHIBBIN
NDC 24338-018, MYCOPHENOLATE MOFETIL, suspension, from Azurity Pharmaceuticals, Inc..
- Product NDC
- 24338-018
- Status
- Listed
- Labeler
- Azurity Pharmaceuticals, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216482
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24338-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MYCOPHENOLATE MOFETIL200 mg/mL
Pharmacologic classes
Antimetabolite Immunosuppressant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24338-018-01 | 24338001801 | 1 BOTTLE, PLASTIC in 1 CARTON (24338-018-01) / 175 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d9af72d6-7b3e-4c08-94b9-1d8b499cb7f9Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=24338-018
Use it
Look up 24338-018 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24338-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24338-018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.